0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
POEMS Syndrome - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-37B12383
Home | Market Reports | Health| Health Conditions
Global POEMS Syndrome Market Research Report 2022
BUY CHAPTERS

POEMS Syndrome - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-37B12383
Report
December 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

POEMS Syndrome - Market Size

The global market for POEMS Syndrome was estimated to be worth US$ 980 million in 2023 and is forecast to a readjusted size of US$ 1428.3 million by 2030 with a CAGR of 5.6% during the forecast period 2024-2030

POEMS Syndrome - Market

POEMS Syndrome - Market

POEMS syndrome is a rare blood disorder that damages your nerves and affects other parts of your body. POEMS stands for these signs and symptoms: Polyneuropathy. Numbness, tingling and weakness in your legs — and over time, maybe in your hands — and difficulty breathing.
The global POEMS syndrome market refers to the market for diagnosing and treating POEMS syndrome, a rare multisystem disorder. POEMS syndrome is a rare plasma cell disorder that affects multiple systems, including the peripheral nerves, bone marrow, and blood vessels. The acronym “POEMS” stands for polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes.
The market for POEMS syndrome is driven by several factors, including the increasing prevalence of the condition, advancements in diagnostic techniques, and the development of targeted treatment options. POEMS syndrome is usually diagnosed through a combination of clinical symptoms, specialized laboratory tests, imaging studies, and biopsy of affected tissues. Accurate and early diagnosis is crucial to initiate appropriate treatment and manage complications.
Treatment options for POEMS syndrome depend on individual patient characteristics, disease severity, and involvement of different systems. The main treatment approach is to target the underlying plasma cell disorder. High-dose chemotherapy with autologous stem cell transplantation (ASCT) is commonly used to achieve disease control and improve outcomes. Immunomodulatory drugs, corticosteroids, and radiation therapy may also be used alone or in combination.
Geographically, North America and Europe are major contributors to the global POEMS syndrome market due to well-established healthcare systems, advanced treatment facilities, and a higher prevalence of the condition. The market in the Asia-Pacific region is also expanding due to improving healthcare infrastructure, increased awareness, and rising cases of POEMS syndrome. There may be geographical variations in disease presentation, management, and access to treatment options.
Key players in the global POEMS syndrome market include pharmaceutical companies, research institutions, and healthcare providers specialized in hematologic malignancies. These players focus on developing novel treatment options, conducting clinical trials, and collaborating with patients and patient advocacy groups to improve patient outcomes and quality of life.
Challenges in the market include the rarity of the condition, delayed diagnosis due to variable and non-specific symptoms, and limited understanding of the disease mechanisms. Research efforts are ongoing to better understand the pathogenesis of POEMS syndrome and explore new therapeutic targets. Early detection, multidisciplinary management, and ongoing medical care are crucial for improving outcomes in POEMS syndrome patients.
In summary, the global POEMS syndrome market is driven by factors such as the increasing prevalence of the condition, advancements in diagnostic techniques, and the development of targeted treatment options. North America and Europe currently lead the market, but the Asia-Pacific region is also growing. Key players in the market continue to focus on research and development to improve patient outcomes and overall quality of life.

Report Scope

This report aims to provide a comprehensive presentation of the global market for POEMS Syndrome, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of POEMS Syndrome by region & country, by Type, and by Application.
The POEMS Syndrome market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding POEMS Syndrome.
Market Segmentation

Scope of POEMS Syndrome - Market Report

Report Metric Details
Report Name POEMS Syndrome - Market
Forecasted market size in 2030 US$ 1428.3 million
CAGR 5.6%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Bristol Myers Squibb, Baxter International, Genentech, Takeda Pharmaceuticals U.S.A., Oncopeptides, Acrotech Biopharma LLC, LGM Pharma, LLC, Jubilant Cadista Pharmaceuticals Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of POEMS Syndrome manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of POEMS Syndrome in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of POEMS Syndrome in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the POEMS Syndrome - Market size in 2030?

Ans: The POEMS Syndrome - Market size in 2030 will be US$ 1428.3 million.

Who are the main players in the POEMS Syndrome - Market report?

Ans: The main players in the POEMS Syndrome - Market are Pfizer, Bristol Myers Squibb, Baxter International, Genentech, Takeda Pharmaceuticals U.S.A., Oncopeptides, Acrotech Biopharma LLC, LGM Pharma, LLC, Jubilant Cadista Pharmaceuticals Inc

What are the Application segmentation covered in the POEMS Syndrome - Market report?

Ans: The Applications covered in the POEMS Syndrome - Market report are Hospitals, Specialty Clinics, Outpatient Surgery Center, Others

What are the Type segmentation covered in the POEMS Syndrome - Market report?

Ans: The Types covered in the POEMS Syndrome - Market report are Chemotherapy, Radiation Therapy, Physical Therapy, Others

Recommended Reports

Syndrome Treatment Markets

Neurological Disease Markets

Blood Disorder Markets

1 Market Overview
1.1 POEMS Syndrome Product Introduction
1.2 Global POEMS Syndrome Market Size Forecast
1.3 POEMS Syndrome Market Trends & Drivers
1.3.1 POEMS Syndrome Industry Trends
1.3.2 POEMS Syndrome Market Drivers & Opportunity
1.3.3 POEMS Syndrome Market Challenges
1.3.4 POEMS Syndrome Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global POEMS Syndrome Players Revenue Ranking (2023)
2.2 Global POEMS Syndrome Revenue by Company (2019-2024)
2.3 Key Companies POEMS Syndrome Manufacturing Base Distribution and Headquarters
2.4 Key Companies POEMS Syndrome Product Offered
2.5 Key Companies Time to Begin Mass Production of POEMS Syndrome
2.6 POEMS Syndrome Market Competitive Analysis
2.6.1 POEMS Syndrome Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by POEMS Syndrome Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POEMS Syndrome as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chemotherapy
3.1.2 Radiation Therapy
3.1.3 Physical Therapy
3.1.4 Others
3.2 Global POEMS Syndrome Sales Value by Type
3.2.1 Global POEMS Syndrome Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global POEMS Syndrome Sales Value, by Type (2019-2030)
3.2.3 Global POEMS Syndrome Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Specialty Clinics
4.1.3 Outpatient Surgery Center
4.1.4 Others
4.2 Global POEMS Syndrome Sales Value by Application
4.2.1 Global POEMS Syndrome Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global POEMS Syndrome Sales Value, by Application (2019-2030)
4.2.3 Global POEMS Syndrome Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global POEMS Syndrome Sales Value by Region
5.1.1 Global POEMS Syndrome Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global POEMS Syndrome Sales Value by Region (2019-2024)
5.1.3 Global POEMS Syndrome Sales Value by Region (2025-2030)
5.1.4 Global POEMS Syndrome Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America POEMS Syndrome Sales Value, 2019-2030
5.2.2 North America POEMS Syndrome Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe POEMS Syndrome Sales Value, 2019-2030
5.3.2 Europe POEMS Syndrome Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific POEMS Syndrome Sales Value, 2019-2030
5.4.2 Asia Pacific POEMS Syndrome Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America POEMS Syndrome Sales Value, 2019-2030
5.5.2 South America POEMS Syndrome Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa POEMS Syndrome Sales Value, 2019-2030
5.6.2 Middle East & Africa POEMS Syndrome Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions POEMS Syndrome Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions POEMS Syndrome Sales Value
6.3 United States
6.3.1 United States POEMS Syndrome Sales Value, 2019-2030
6.3.2 United States POEMS Syndrome Sales Value by Type (%), 2023 VS 2030
6.3.3 United States POEMS Syndrome Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe POEMS Syndrome Sales Value, 2019-2030
6.4.2 Europe POEMS Syndrome Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe POEMS Syndrome Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China POEMS Syndrome Sales Value, 2019-2030
6.5.2 China POEMS Syndrome Sales Value by Type (%), 2023 VS 2030
6.5.3 China POEMS Syndrome Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan POEMS Syndrome Sales Value, 2019-2030
6.6.2 Japan POEMS Syndrome Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan POEMS Syndrome Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea POEMS Syndrome Sales Value, 2019-2030
6.7.2 South Korea POEMS Syndrome Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea POEMS Syndrome Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia POEMS Syndrome Sales Value, 2019-2030
6.8.2 Southeast Asia POEMS Syndrome Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia POEMS Syndrome Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India POEMS Syndrome Sales Value, 2019-2030
6.9.2 India POEMS Syndrome Sales Value by Type (%), 2023 VS 2030
6.9.3 India POEMS Syndrome Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Profile
7.1.2 Pfizer Main Business
7.1.3 Pfizer POEMS Syndrome Products, Services and Solutions
7.1.4 Pfizer POEMS Syndrome Revenue (US$ Million) & (2019-2024)
7.1.5 Pfizer Recent Developments
7.2 Bristol Myers Squibb
7.2.1 Bristol Myers Squibb Profile
7.2.2 Bristol Myers Squibb Main Business
7.2.3 Bristol Myers Squibb POEMS Syndrome Products, Services and Solutions
7.2.4 Bristol Myers Squibb POEMS Syndrome Revenue (US$ Million) & (2019-2024)
7.2.5 Bristol Myers Squibb Recent Developments
7.3 Baxter International
7.3.1 Baxter International Profile
7.3.2 Baxter International Main Business
7.3.3 Baxter International POEMS Syndrome Products, Services and Solutions
7.3.4 Baxter International POEMS Syndrome Revenue (US$ Million) & (2019-2024)
7.3.5 Genentech Recent Developments
7.4 Genentech
7.4.1 Genentech Profile
7.4.2 Genentech Main Business
7.4.3 Genentech POEMS Syndrome Products, Services and Solutions
7.4.4 Genentech POEMS Syndrome Revenue (US$ Million) & (2019-2024)
7.4.5 Genentech Recent Developments
7.5 Takeda Pharmaceuticals U.S.A.
7.5.1 Takeda Pharmaceuticals U.S.A. Profile
7.5.2 Takeda Pharmaceuticals U.S.A. Main Business
7.5.3 Takeda Pharmaceuticals U.S.A. POEMS Syndrome Products, Services and Solutions
7.5.4 Takeda Pharmaceuticals U.S.A. POEMS Syndrome Revenue (US$ Million) & (2019-2024)
7.5.5 Takeda Pharmaceuticals U.S.A. Recent Developments
7.6 Oncopeptides
7.6.1 Oncopeptides Profile
7.6.2 Oncopeptides Main Business
7.6.3 Oncopeptides POEMS Syndrome Products, Services and Solutions
7.6.4 Oncopeptides POEMS Syndrome Revenue (US$ Million) & (2019-2024)
7.6.5 Oncopeptides Recent Developments
7.7 Acrotech Biopharma LLC
7.7.1 Acrotech Biopharma LLC Profile
7.7.2 Acrotech Biopharma LLC Main Business
7.7.3 Acrotech Biopharma LLC POEMS Syndrome Products, Services and Solutions
7.7.4 Acrotech Biopharma LLC POEMS Syndrome Revenue (US$ Million) & (2019-2024)
7.7.5 Acrotech Biopharma LLC Recent Developments
7.8 LGM Pharma, LLC
7.8.1 LGM Pharma, LLC Profile
7.8.2 LGM Pharma, LLC Main Business
7.8.3 LGM Pharma, LLC POEMS Syndrome Products, Services and Solutions
7.8.4 LGM Pharma, LLC POEMS Syndrome Revenue (US$ Million) & (2019-2024)
7.8.5 LGM Pharma, LLC Recent Developments
7.9 Jubilant Cadista Pharmaceuticals Inc
7.9.1 Jubilant Cadista Pharmaceuticals Inc Profile
7.9.2 Jubilant Cadista Pharmaceuticals Inc Main Business
7.9.3 Jubilant Cadista Pharmaceuticals Inc POEMS Syndrome Products, Services and Solutions
7.9.4 Jubilant Cadista Pharmaceuticals Inc POEMS Syndrome Revenue (US$ Million) & (2019-2024)
7.9.5 Jubilant Cadista Pharmaceuticals Inc Recent Developments
8 Industry Chain Analysis
8.1 POEMS Syndrome Industrial Chain
8.2 POEMS Syndrome Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 POEMS Syndrome Sales Model
8.5.2 Sales Channel
8.5.3 POEMS Syndrome Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. POEMS Syndrome Market Trends
    Table 2. POEMS Syndrome Market Drivers & Opportunity
    Table 3. POEMS Syndrome Market Challenges
    Table 4. POEMS Syndrome Market Restraints
    Table 5. Global POEMS Syndrome Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global POEMS Syndrome Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies POEMS Syndrome Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies POEMS Syndrome Product Type
    Table 9. Key Companies Time to Begin Mass Production of POEMS Syndrome
    Table 10. Global POEMS Syndrome Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POEMS Syndrome as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global POEMS Syndrome Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global POEMS Syndrome Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global POEMS Syndrome Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global POEMS Syndrome Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global POEMS Syndrome Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global POEMS Syndrome Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global POEMS Syndrome Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global POEMS Syndrome Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global POEMS Syndrome Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global POEMS Syndrome Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global POEMS Syndrome Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global POEMS Syndrome Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global POEMS Syndrome Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global POEMS Syndrome Sales Value by Region (2019-2024) & (%)
    Table 27. Global POEMS Syndrome Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions POEMS Syndrome Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions POEMS Syndrome Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions POEMS Syndrome Sales Value, (2025-2030) & (US$ Million)
    Table 31. Pfizer Basic Information List
    Table 32. Pfizer Description and Business Overview
    Table 33. Pfizer POEMS Syndrome Products, Services and Solutions
    Table 34. Revenue (US$ Million) in POEMS Syndrome Business of Pfizer (2019-2024)
    Table 35. Pfizer Recent Developments
    Table 36. Bristol Myers Squibb Basic Information List
    Table 37. Bristol Myers Squibb Description and Business Overview
    Table 38. Bristol Myers Squibb POEMS Syndrome Products, Services and Solutions
    Table 39. Revenue (US$ Million) in POEMS Syndrome Business of Bristol Myers Squibb (2019-2024)
    Table 40. Bristol Myers Squibb Recent Developments
    Table 41. Baxter International Basic Information List
    Table 42. Baxter International Description and Business Overview
    Table 43. Baxter International POEMS Syndrome Products, Services and Solutions
    Table 44. Revenue (US$ Million) in POEMS Syndrome Business of Baxter International (2019-2024)
    Table 45. Baxter International Recent Developments
    Table 46. Genentech Basic Information List
    Table 47. Genentech Description and Business Overview
    Table 48. Genentech POEMS Syndrome Products, Services and Solutions
    Table 49. Revenue (US$ Million) in POEMS Syndrome Business of Genentech (2019-2024)
    Table 50. Genentech Recent Developments
    Table 51. Takeda Pharmaceuticals U.S.A. Basic Information List
    Table 52. Takeda Pharmaceuticals U.S.A. Description and Business Overview
    Table 53. Takeda Pharmaceuticals U.S.A. POEMS Syndrome Products, Services and Solutions
    Table 54. Revenue (US$ Million) in POEMS Syndrome Business of Takeda Pharmaceuticals U.S.A. (2019-2024)
    Table 55. Takeda Pharmaceuticals U.S.A. Recent Developments
    Table 56. Oncopeptides Basic Information List
    Table 57. Oncopeptides Description and Business Overview
    Table 58. Oncopeptides POEMS Syndrome Products, Services and Solutions
    Table 59. Revenue (US$ Million) in POEMS Syndrome Business of Oncopeptides (2019-2024)
    Table 60. Oncopeptides Recent Developments
    Table 61. Acrotech Biopharma LLC Basic Information List
    Table 62. Acrotech Biopharma LLC Description and Business Overview
    Table 63. Acrotech Biopharma LLC POEMS Syndrome Products, Services and Solutions
    Table 64. Revenue (US$ Million) in POEMS Syndrome Business of Acrotech Biopharma LLC (2019-2024)
    Table 65. Acrotech Biopharma LLC Recent Developments
    Table 66. LGM Pharma, LLC Basic Information List
    Table 67. LGM Pharma, LLC Description and Business Overview
    Table 68. LGM Pharma, LLC POEMS Syndrome Products, Services and Solutions
    Table 69. Revenue (US$ Million) in POEMS Syndrome Business of LGM Pharma, LLC (2019-2024)
    Table 70. LGM Pharma, LLC Recent Developments
    Table 71. Jubilant Cadista Pharmaceuticals Inc Basic Information List
    Table 72. Jubilant Cadista Pharmaceuticals Inc Description and Business Overview
    Table 73. Jubilant Cadista Pharmaceuticals Inc POEMS Syndrome Products, Services and Solutions
    Table 74. Revenue (US$ Million) in POEMS Syndrome Business of Jubilant Cadista Pharmaceuticals Inc (2019-2024)
    Table 75. Jubilant Cadista Pharmaceuticals Inc Recent Developments
    Table 76. Key Raw Materials Lists
    Table 77. Raw Materials Key Suppliers Lists
    Table 78. POEMS Syndrome Downstream Customers
    Table 79. POEMS Syndrome Distributors List
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
    Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. POEMS Syndrome Product Picture
    Figure 2. Global POEMS Syndrome Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global POEMS Syndrome Sales Value (2019-2030) & (US$ Million)
    Figure 4. POEMS Syndrome Report Years Considered
    Figure 5. Global POEMS Syndrome Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by POEMS Syndrome Revenue in 2023
    Figure 7. POEMS Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Chemotherapy Picture
    Figure 9. Radiation Therapy Picture
    Figure 10. Physical Therapy Picture
    Figure 11. Others Picture
    Figure 12. Global POEMS Syndrome Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global POEMS Syndrome Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Hospitals
    Figure 15. Product Picture of Specialty Clinics
    Figure 16. Product Picture of Outpatient Surgery Center
    Figure 17. Product Picture of Others
    Figure 18. Global POEMS Syndrome Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global POEMS Syndrome Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America POEMS Syndrome Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America POEMS Syndrome Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe POEMS Syndrome Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe POEMS Syndrome Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific POEMS Syndrome Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific POEMS Syndrome Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America POEMS Syndrome Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America POEMS Syndrome Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa POEMS Syndrome Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa POEMS Syndrome Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions POEMS Syndrome Sales Value (%), (2019-2030)
    Figure 31. United States POEMS Syndrome Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States POEMS Syndrome Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States POEMS Syndrome Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe POEMS Syndrome Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe POEMS Syndrome Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe POEMS Syndrome Sales Value by Application (%), 2023 VS 2030
    Figure 37. China POEMS Syndrome Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China POEMS Syndrome Sales Value by Type (%), 2023 VS 2030
    Figure 39. China POEMS Syndrome Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan POEMS Syndrome Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan POEMS Syndrome Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan POEMS Syndrome Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea POEMS Syndrome Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea POEMS Syndrome Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea POEMS Syndrome Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia POEMS Syndrome Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia POEMS Syndrome Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia POEMS Syndrome Sales Value by Application (%), 2023 VS 2030
    Figure 49. India POEMS Syndrome Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India POEMS Syndrome Sales Value by Type (%), 2023 VS 2030
    Figure 51. India POEMS Syndrome Sales Value by Application (%), 2023 VS 2030
    Figure 52. POEMS Syndrome Industrial Chain
    Figure 53. POEMS Syndrome Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Z7671
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10V14317
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O5919
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I19963
Thu Sep 18 00:00:00 UTC 2025

Add to Cart